Difference between revisions of "Scientific Articles on Psychedelics"
From DMT-Nexus Wiki
TheTraveler (Talk | contribs) (→Other) |
Endlessness (Talk | contribs) (→Other) |
||
| (4 intermediate revisions by one user not shown) | |||
| Line 1: | Line 1: | ||
| − | {{ShowInfo|[[Image:Error.png]]|'''Note:'''|This page is a work in progress -- its content throughout is not yet complete.}} | + | {{ShowInfo|[[Image:Error.png]]|'''Note:'''|This page is a work in progress -- its content throughout is not yet complete.}}<br /> |
| − | + | ||
| − | + | ||
==Ayahuasca== | ==Ayahuasca== | ||
{{FileReference | {{FileReference | ||
| Line 104: | Line 102: | ||
| | | | ||
}} | }} | ||
| + | |||
==DMT== | ==DMT== | ||
| Line 127: | Line 126: | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media:DMT psychopharmacology.pdf|DMT psychopharmacology]] | |[[Media:DMT psychopharmacology.pdf|DMT psychopharmacology]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| | | | ||
}} | }} | ||
| + | |||
==Ibogaine== | ==Ibogaine== | ||
| Line 166: | Line 160: | ||
| | | | ||
}} | }} | ||
| + | |||
==LSD== | ==LSD== | ||
| Line 179: | Line 174: | ||
| | | | ||
}} | }} | ||
| + | |||
==Peyote== | ==Peyote== | ||
| Line 198: | Line 194: | ||
| | | | ||
}} | }} | ||
| + | |||
==Psilocybin== | ==Psilocybin== | ||
| Line 247: | Line 244: | ||
| | | | ||
}} | }} | ||
| + | |||
==Salvia Divinorum== | ==Salvia Divinorum== | ||
| Line 260: | Line 258: | ||
| | | | ||
}} | }} | ||
| + | |||
==Other== | ==Other== | ||
| + | {{FileReference | ||
| + | |[[Image:Page_white_acrobat.png]] | ||
| + | |[[Media:Jf00077a037.pdf|Alkaloidal insect antifeedants from Virola calophylla]] | ||
| + | |Howard Miles, Ana Maria Ly, Shirley A. Randle, Paul A. Hedin, Marcus L. Burks Warb Journal of agricultural and food chemistry September 1987 Volume 35, Issue 5 D pp 794–797 | ||
| + | |0px | ||
| + | }} | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
Latest revision as of 11:43, 24 October 2011
 |
Note: | This page is a work in progress -- its content throughout is not yet complete. |
Ayahuasca
|
Ayahuasca and SSRI Interactions | Callaway, J.T., C.S. Grob. (October-December 1998). Journal of Psychoactive Drugs. pp. 367-369. |
|
|
Ayahuasca Adolescents ritual use | Doering-Silveira et al. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2). pp. 141-144. |
|
|
ayahuasca first time psychological after effects | Hoffman et al. (Spring 2001). Multidisciplinary Association for Psychedelic Studies. pp. 25-30. |
|
|
Ayahuasca and human destiny | McKenna, Dennis J. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2) pp. 231-234. |
|
|
Another Ayahuasca EEG study | Riba et al. (2002). British Journal of Clinical Pharmacology. Vol. 53. Blackwell Science Ltd. pp. 617-628. |
|
|
Ayahuasca in adolescence psychiatric evaluation |
|
|
ayahuasca in cross cultural perspective |
|
|
Ayahuasca neuroimaging |
|
|
Bringing Ayahuasca to clinical laboratory |
|
|
Effects of ayahuasca on panic and anxiety.pdf |
|
|
Globalization of ayahuasca |
|
|
Human pharmacology of ayahuasca |
|
|
Pharmacokinetics of hoasca in healthy humans |
|
|
Risk assessment of ritual ayahuasca use |
|
|
Thesis - Ayahuascapharmacology part1 |
|
|
Thesis - ayahuascapharmacology part2 |
|
|
Various alkaloid profiles in aya decoction |
DMT
|
|
DMT and BCarbolines in human plasma after dose |
|
|
DMT endogenous anxiolytic role |
|
|
DMT in psychiatric patients |
|
|
DMT psychopharmacology |
Ibogaine
|
|
Fatalities after ibogaine use |
|
|
Ibogaine and cocaine abuse |
|
|
Ibogaine and facilitation of memory retrieval |
|
|
Ibogaine mechanisms of anti addiction |
|
|
Ibogaine safety and efficacy |
LSD
|
|
Long term effects of LSD |
|
|
Therapy with LSD |
Peyote
|
|
A Study on mescaline in human subjects |
|
|
Peyote long term psychological cognitive effects |
|
|
Prehistoric peyote use |
Psilocybin
|
|
Cluster headache lsd psilocybin |
|
|
Effects of psilocybin on humans |
|
|
Effects of psilocybin on perception of time |
|
|
Psilocybin and mystical experiences |
|
|
Psilocybin and OCD |
|
|
Psilocybin investigator brochure |
|
|
Psilocybin, attention and working memory |
|
|
Psychedelic mushrooms in buddhist tradition |
Salvia Divinorum
|
|
Salvia divinorum pattern of use |
|
|
Salv_A_PNAS |
Other
|
|
Alkaloidal insect antifeedants from Virola calophylla | Howard Miles, Ana Maria Ly, Shirley A. Randle, Paul A. Hedin, Marcus L. Burks Warb Journal of agricultural and food chemistry September 1987 Volume 35, Issue 5 D pp 794–797 |
|
|
Bufo alvarius - a potent hallucinogen |
|
|
Entheogens and education potential |
|
|
Hallucinogens and redemption |
|
|
HPPD - flashbacks |
|
|
JPharmBioAn-41-3-872 |
|
|
Mining_Recepterome_Review_JBC |
|
|
Natural hallucinogens growing in USA |
|
|
Nichols - Hallucinogens |
|
|
Pharmañopo - Yopo pharmacology |
|
|
Pharmepena - epena pharmacology |
|
|
Proposed Mechanism for Dreams and Sleep |
|
|
Psychedelic adverse effects |
|
|
Psychointegrators multidisciplinary approach |
|
|
Psychopharmacology of hallucinogens |
|
|
Psychosis and hallucinogens consciousness model |
|
|
Reducing drug problems with set and setting |
|
|
Serotonin and hallucinogens |
|
|
Study of Values of psychedelic users |
